EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distribution of citalopram enantiomers following medication with racemic citalopram - a naturalistic therapeutic drug monitoring study

Ketil Arne Espnes, Arne Hønnås, Eirik Skogvoll, Olav Spigset

European Journal of Clinical Pharmacology · 2026-08 · 82 (8)

DOI: 10.1007/s00228-026-04148-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 24.07.2026. Verfasst von Ketil Arne Espnes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, St. Olavs Hospital, Trondheim University Hospital, Torgarden, P.O. Box 3250, 7006, Trondheim, Norway. ketil.arne…. Hauptthemen laut MEDLINE: Citalopram, Selective Serotonin Reuptake Inhibitors. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NTNU Norwegian University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

There are very few reports describing to which extent sex, age, dose and time from dose intake affect the enantiomeric distribution during treatment with citalopram. The aim of the present study was to quantify the impact of these factors on the active S-enantiomer during treatment with citalopram.

Methods

Samples analysed for citalopram in a routine therapeutic drug monitoring setting were included. The analytical method consisted of enantiomeric separation and quantification of R- and S-citalopram. We employed a linear mixed model to account for multiple samples from the same patient.

Results

A total of 305 samples was included. The mean (± SD) proportion of S-citalopram in the total sample was 34.2 ± 8.1%, corresponding to a mean S/R ratio of 0.52 ± 0.17. According to the linear mixed model, the proportion of S-citalopram increased with 0.69 percentage points per decade of age. Increasing the time interval from dose intake to sampling reduced this proportion with 1.10 percentage points every 6 h. For example, if the sample was obtained 24 h after intake in a person aged 40, the proportion of S-citalopram was 32.7%; while if the sample was obtained 12 h after intake the proportion was 34.9%. Sex and dose did not impact significantly.

Conclusion

The percentage of S-citalopram in plasma during treatment with citalopram increased with patient age and decreased with the time from dose intake. In contrast, sex and dose did not significantly affect the percentage of S-citalopram.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CitalopramSelective Serotonin Reuptake InhibitorsHumansStereoisomerismFemaleDrug MonitoringMaleMiddle AgedAdultAgedYoung AdultAge Factors

Stichwörter der Autor:innen

CitalopramEnantiomersPharmacokineticsRacemic intake

Substanzen

CitalopramSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, St. Olavs Hospital, Trondheim University Hospital, Torgarden, P.O. Box 3250, 7006, Trondheim, Norway. ketil.arne.espnes@stolav.no.
  • Department of Clinical Pharmacology, St. Olavs Hospital, Trondheim University Hospital, Torgarden, P.O. Box 3250, 7006, Trondheim, Norway.
  • Clinic of Anaesthesia and Intensive Care, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
  • Department of Circulation and Medical Imaging (ISB), Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Department of Clinical and Molecular Medicine (IKOM), Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.

Förderung

  • NTNU Norwegian University of Science and Technology

Zitieren

APA

Espnes, K. A., Hønnås, A., Skogvoll, E., & Spigset, O. (2026). Distribution of citalopram enantiomers following medication with racemic citalopram - a naturalistic therapeutic drug monitoring study. European Journal of Clinical Pharmacology, 82(8). https://doi.org/10.1007/s00228-026-04148-x

Vancouver

Espnes KA, Hønnås A, Skogvoll E, Spigset O. Distribution of citalopram enantiomers following medication with racemic citalopram - a naturalistic therapeutic drug monitoring study. European Journal of Clinical Pharmacology. 2026;82(8). doi:10.1007/s00228-026-04148-x

BibTeX
@article{Espnes2026,
  author = {Espnes, Ketil Arne and Hønnås, Arne and Skogvoll, Eirik and Spigset, Olav},
  title = {Distribution of citalopram enantiomers following medication with racemic citalopram - a naturalistic therapeutic drug monitoring study},
  journal = {European Journal of Clinical Pharmacology},
  year = {2026},
  volume = {82},
  number = {8},
  doi = {10.1007/s00228-026-04148-x}
}
Kostenlos starten →